Common Stock, Shares, Outstanding of Arcus Biosciences, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Arcus Biosciences, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Arcus Biosciences, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 125,300,000, a 36% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Arcus Biosciences, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 125,300,000 +33,100,000 +36% 31 Dec 2025 10-K 25 Feb 2026 2025 FY
Q3 2025 107,100,000 +15,600,000 +17% 30 Sep 2025 10-Q 28 Oct 2025 2025 Q3
Q2 2025 106,400,000 +15,100,000 +17% 30 Jun 2025 10-Q 06 Aug 2025 2025 Q2
Q1 2025 105,900,000 +15,000,000 +17% 31 Mar 2025 10-Q 06 May 2025 2025 Q1
Q4 2024 92,200,000 +16,700,000 +22% 31 Dec 2024 10-K 25 Feb 2026 2025 FY
Q3 2024 91,500,000 +16,700,000 +22% 30 Sep 2024 10-Q 06 Nov 2024 2024 Q3
Q2 2024 91,300,000 +16,800,000 +23% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 90,900,000 +17,800,000 +24% 31 Mar 2024 10-Q 08 May 2024 2024 Q1
Q4 2023 75,500,000 +2,600,000 +3.6% 31 Dec 2023 10-K 25 Feb 2025 2024 FY
Q3 2023 74,800,000 +2,447,620 +3.4% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 74,500,000 +2,414,527 +3.4% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 73,100,000 +1,477,687 +2.1% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 72,900,000 +2,100,000 +3% 31 Dec 2022 10-K 21 Feb 2024 2023 FY
Q3 2022 72,352,380 +2,110,790 +3% 30 Sep 2022 10-Q 02 Nov 2022 2022 Q3
Q2 2022 72,085,473 +711,414 +1% 30 Jun 2022 10-Q 03 Aug 2022 2022 Q2
Q1 2022 71,622,313 +656,800 +0.93% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 70,800,000 +5,685,315 +8.7% 31 Dec 2021 10-K 28 Feb 2023 2022 FY
Q3 2021 70,241,590 +5,317,517 +8.2% 30 Sep 2021 10-Q 08 Nov 2021 2021 Q3
Q2 2021 71,374,059 +12,433,126 +21% 30 Jun 2021 10-Q 05 Aug 2021 2021 Q2
Q1 2021 70,965,513 +24,982,725 +54% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 65,114,685 +19,189,681 +42% 31 Dec 2020 10-K 23 Feb 2022 2021 FY
Q3 2020 64,924,073 +19,081,107 +42% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q2 2020 58,940,933 +13,086,720 +29% 30 Jun 2020 10-Q 06 Aug 2020 2020 Q2
Q1 2020 45,982,788 +1,448,194 +3.3% 31 Mar 2020 10-Q 05 May 2020 2020 Q1
Q4 2019 45,925,004 +1,387,058 +3.1% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 45,842,966 +1,389,242 +3.1% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 45,854,213 +1,397,554 +3.1% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 44,534,594 +80,319 +0.18% 31 Mar 2019 10-Q 02 May 2019 2019 Q1
Q4 2018 44,537,946 +40,447,048 +989% 31 Dec 2018 10-K 05 Mar 2020 2019 FY
Q3 2018 44,453,724 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 44,456,659 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 44,454,275 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 4,090,898 31 Dec 2017 10-K 05 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.